PFF vs XBI
iShares Preferred & Income Securities ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.45% for PFF.
- • PFF pays a higher dividend yield (5.73%).
Side-by-side metrics
| Metric | PFF | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.45% | 0.35% |
Dividend yield Trailing 12-month yield. | 5.73% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $11.67B | $10.92B |
YTD return | -3.28% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.79 | 1.01 |
P/E ratio | 3.52 | — |
Last price | $28.36 | $156.41 |
Inception | — | — |
Issuer | iShares | State Street |
PFF top holdings
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 1.30% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About PFF
PFF (iShares Preferred & Income Securities ETF) is US preferred stocks and hybrid income securities. Managed by iShares, the fund carries $11.7B in assets under management, an expense ratio of 0.45%, a dividend yield of 5.73%. Its largest holding is BlackRock Cash Funds Treasury SL Agency (XTSLA), which represents 1.3% of the portfolio. Technology is the fund's largest sector exposure at 5.9%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.